Update on Pathogenesis. Front Pharmacol. 2021;12:797292. \[[PMC free article: PMC8807692](/pmc/articles/PMC8807692/)\] \[[PubMed: 35126134](https://pubmed.ncbi.nlm.nih.gov/35126134)\] 7. Günther A, Korfei M, Mahavadi P, von der Beck D, Ruppert C, Markart P. Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis. Eur Respir Rev. 2012 Jun 01;21(124):152-60. \[[PMC free article: PMC9487300](/pmc/articles/PMC9487300/)\] \[[PubMed: 22654088](https://pubmed.ncbi.nlm.nih.gov/22654088)\] 8. Heukels P, Moor CC, von der Thüsen JH, Wijsenbeek MS, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 2019 Feb;147:79-91. \[[PubMed: 30704705](https://pubmed.ncbi.nlm.nih.gov/30704705)\] 9. Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G. Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respir Res. 2021 Apr 17;22(1):109. \[[PMC free article: PMC8052779](/pmc/articles/PMC8052779/)\] \[[PubMed: 33865386](https://pubmed.ncbi.nlm.nih.gov/33865386)\] 10. Bano A, Chaker L, Muka T, Mattace-Raso FUS, Bally L, Franco OH, Peeters RP, Razvi S. Thyroid Function and the Risk of Fibrosis of the Liver, Heart, and Lung in Humans: A Systematic Review and Meta-Analysis. Thyroid. 2020 Jun;30(6):806-820. \[[PubMed: 31910097](https://pubmed.ncbi.nlm.nih.gov/31910097)\] 11. Zhang L, Wang Y, Wu G, Xiong W, Gu W, Wang CY. Macrophages: friend or foe in idiopathic pulmonary fibrosis? Respir Res. 2018 Sep 06;19(1):170. \[[PMC free article: PMC6127991](/pmc/articles/PMC6127991/)\] \[[PubMed: 30189872](https://pubmed.ncbi.nlm.nih.gov/30189872)\] 12. Shioya M, Otsuka M, Yamada G, Umeda Y, Ikeda K, Nishikiori H, Kuronuma K, Chiba H, Takahashi H. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage. Can Respir J. 2018;2018:6043053. \[[PMC free article: PMC6110001](/pmc/articles/PMC6110001/)\] \[[PubMed: 30186537](https://pubmed.ncbi.nlm.nih.gov/30186537)\] 13. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015 Sep;46(3):795-806. \[[PubMed: 25976683](https://pubmed.ncbi.nlm.nih.gov/25976683)\] 14. Esposito DB, Lanes S, Donneyong M, Holick CN, Lasky JA, Lederer D, Nathan SD, O'Quinn S, Parker J, Tran TN. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation. Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. \[[PubMed: 26241562](https://pubmed.ncbi.nlm.nih.gov/26241562)\] 15. Olson AL, Gifford AH, Inase N, Fernández Pérez ER, Suda T. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. Eur Respir Rev. 2018 Dec 31;27(150) \[[PMC free article: PMC9489016](/pmc/articles/PMC9489016/)\] \[[PubMed: 30578336](https://pubmed.ncbi.nlm.nih.gov/30578336)\] 16. Harari S, Madotto F, Caminati A, Conti S, Cesana G. Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy. PLoS One. 2016;11(2):e0147072. \[[PMC free article: PMC4740484](/pmc/articles/PMC4740484/)\] \[[PubMed: 26841042](https://pubmed.ncbi.nlm.nih.gov/26841042)\] 17. Mostafaei S, Sayad B, Azar MEF, Doroudian M, Hadifar S, Behrouzi A, Riahi P, Hussen BM, Bayat B, Nahand JS, Moghoofei M. The role of viral and bacterial infections in the pathogenesis